17Aug
UK Life Sciences and Healthcare Newsletter - August 2020: COVID-19 – How Have Listed Companies Fared?
COVID-19 has had a significant financial impact on many listed companies and, in recent months, there has been a marked increase in equity capital raises by listed companies. As at 22 July 2020, there have been over 100 secondary equity fundraisings in excess of £10 million on the Main Market and AIM since the COVID lockdown period began. Some have had to raise emergency capital, on short notice and often at significant discounts, whereas others have sought to shore up their balance sheets as...
By:
Dechert LLP
Related
Even as they make their investment, private equity investors are focused on their exit. A standard f...
Read More >
Any illusions that OFCCP would disappear during the Trump Administration should have already been pu...
Read More >
Employees are a company’s most important assets. A key executive or manager can make the difference...
Read More >
Earlier this week, the US Department of Justice published updated guidance on how it evaluates corpo...
Read More >
Hard on the heels of the muckle of anti-trust filings against the huge U.S. technology companies in ...
Read More >
As we previously reported in the context of low-wage workers, Rhode Island recently passed the Rhode...
Read More >